Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD)

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 166-172

  Bregenholt, S ^a   Claesson, M H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

G M CFC; Inflammatory bowel disease; Scid mice; Th1 cytokines

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; ENTERITIS; EXTRAMEDULLARY HEMATOPOIESIS; GIANT CELL; HELPER CELL; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN;

ANIMALS; CYTOKINES; HEMATOPOIESIS; INFLAMMATORY BOWEL DISEASES; MICE; MICE, SCID; SPLEEN; TH1 CELLS;

EID: 0031882328     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00459.x     Document Type: Article

References (40)

1. Bosma GC, Custer RP, Bosma MJ. A severe sombined immunodeficiency mutation in the mouse. Nature 1983; 301:517-30.
2. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 1991; 124:5-24.
3. Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Ann Rev Immunol 1991; 9:323-50.
4. Reimann J, Rudolphi A, Claesson MH. Selective reconstitution of T lymphocyte subsets in scid mice. Immunol Rev 1991; 124:75-95.
5. Bregenholt S, Delbro D, Claesson MH. T cell transfer and cytokine/TCR gene deletion models in the study of inflammatory bowel disease. APMIS 1997; 105:655-62.
6. + T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 1996; 104:491-500.
7. + T cell receptor alpha beta ' T cells in the pathogenesis of murine inflammatory bowel disease. Eur J Immunol 1994; 24:2803-12.
8. Reimann J, Rudolphi A, Claesson MH. Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease. J Mol Med 1995; 73:133-40.
9. + αβ cells in the colonic lamina propria of scid mice with colitis. Eur J Immunol 1996; 26:1156-63.
10. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996; 184:241-51.
11. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995; 25:2618-25.
12. +, T cell receptor BV repertoire of lamina propria lymphocytes. Clin Immunol Immunopathol 1995; 77:95-106.
13. Gulwani-Akolkar B, Akolkar PN, Minassian A et al. Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease. J Clin Invest 1996; 98:1344-54.
14. + lymphocytes in chronic inflammatory bowel disease. J Immunol 1996; 157:3183-91.
15. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
16. Breese B, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-31.
17. + lamina propri (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease EP cells manifest increased secretion of INF-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70.
18. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
19. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996; 80:225-35.
20. Parronchi P, Romagnani P, Annuziato F et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150:823-32.
21. Mahida YR, Jewell DP. Macrophage activity in inflammatory bowel disease. Gut 1990; 31:1086-7.
22. + population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin Exp Immunol 1995; 100:291-7.
23. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 1995; 10:387-95.
24. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35:669-74.
25. + T cell-transplated severe combined immunodeficient mouse model of colitis. Immunol Cell Biol 1997; 75:A112.
26. Metcalf D. Hemopoietic colonies. In vitro cloning of normal and leukemic cells. Berlin: Springer-Verlag, 1977.
27. Claesson MH, Olsson L. Autoreactive natural killer-like cells from agar-cloned murine bone marrow cells. Nature 1980; 283:578-80.
28. Claesson MH, Olsson L, Martinsen L, Brix-Poulsen P. Bone marrow derived diffuse colonies: their cytotoxic potential, morphology, and antigenic phenotype. Exp Hematol 1982; 10:708-21.
29. + T cells. Am J Pathol 1996; 148:1503-15.
30. Carter LL, Swain SL. Single cell analyses of cytokine production. Curr Opin Immunol 1997; 9:177-82.
31. + T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and colour flow cytometry. Clin Exp Immunol 1996; 105:517-22.
32. + αβ T cells in SCID mice with colitis. Eur J Immunol 1996; 26:3074-83.
33. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7:145-73.
34. Munker R, Gasson J, Ogawa M, Koeffler HP. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 1986; 323:79-82.
35. Callard R, Gearing A. The cytokine factsbook. San Diego: Academic Press, 1994.
36. Wang JM, Colella S, Allavena P, Mantovani A. Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology 1987; 60:439-44.
37. Mizoguchi A, Mizozuchi E, Chiba C et al. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996; 183:847-56.
38. + T cells in an experimental model of colitis. Eur J Immunol 1997; 27:17-25.
39. + T cell and proinflammatory Th1-type cytokines. J Immunol 1997; 158:1068-77.
40. McDonald SAC, Palmen MJHJ, van Rees EP, MacDonald TT. Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after onset of colitis. Immunology 1997; 91:73-80.